Related Experiment Videos

Adenosine A2A receptor knockout mice are partially protected against drug-induced catalepsy

M El Yacoubi1, C Ledent, M Parmentier

  • 1UMR 6036 CNRS, IFRMP 23, UFR de Médecine and Pharmacie, Rouen, France.

Neuroreport
|April 17, 2001
PubMed

Insights

Adenosine A2A receptors modulate dopamine and acetylcholine pathways. A2A receptor knockout mice showed reduced catalepsy, indicating these receptors influence motor control.

Area of Science:

  • Neuroscience
  • Pharmacology

Background:

  • Adenosine A2A receptors are implicated in modulating dopaminergic neurotransmission.
  • The precise role of adenosine A2A receptors in other neurotransmitter systems, like cholinergic pathways, remains less understood.

Purpose of the Study:

  • To investigate the role of adenosine A2A receptors in catalepsy induced by dopaminergic and cholinergic agents.
  • To compare the effects of cataleptogenic drugs in adenosine A2A receptor knockout (A2AR KO) and wild-type (A2AR WT) mice.

Main Methods:

  • Catalepsy was assessed using the bar test in A2AR KO and A2AR WT mice.
  • Mice were administered haloperidol (D2 antagonist), SCH 23390 (D1 antagonist), reserpine (vesicular monoamine transporter blocker), or pilocarpine (muscarinic agonist).

Main Results:

  • A2AR KO mice exhibited significantly lower catalepsy scores compared to A2AR WT mice, except when treated with reserpine.
  • This reduction in catalepsy was observed following acute administration of low doses of haloperidol, SCH 23390, and pilocarpine.

Conclusions:

  • Adenosine A2A receptors play a significant role in modulating both dopamine D1/D2 receptor-mediated and acetylcholine muscarinic receptor-mediated neurotransmission.
  • These findings highlight the broader influence of adenosine A2A receptors on motor control and neurotransmitter systems beyond dopamine.

Related Concept Videos